common.study.topics.clinical

Improving Cognition in Schizophrenia

common.study.values.description

“Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia”

This study plans to learn more about the effects of levetiracetam (LEV) on brain activity and cognition in schizophrenia and schizoaffective disorder. Levetiracetam is an anti-seizure drug, also called an anticonvulsant.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Levetiracetam

Anticonvulsant drug

Drug - Placebo

Placebo

participant.views.study.view.additional

participant.views.study.view.scientific-title

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

common.study.values.clinical-trial-id

NCT03034356

participant.views.study.view.id

xbokBb